Coenzyme Q-10 reduced the aberrant production of extracellular matrix proteins in uterine leiomyomas through transforming growth factor beta 3
- 14 July 2024
- journal article
- research article
- Published by Elsevier in F&S Science
- Vol. 5 (4) , 342-351
Abstract
No abstract availableKeywords
Funding Information
- Uniformed Services University of the Health Sciences
This publication has 42 references indexed in Scilit:
- Coenzyme Q10 Supplementation in Fibrosis and Aging2019
- Ulipristal acetate decreases active TGF-β3 and its canonical signaling in uterine leiomyoma via two novel mechanismsFertility and Sterility, 2019
- Coenzyme Q10 attenuates lung and liver fibrosis via modulation of autophagy in methotrexate treated ratBiomedicine & Pharmacotherapy, 2019
- Protective effect of Co‐enzyme Q10 On doxorubicin‐induced cardiomyopathy of rat heartsEnvironmental Toxicology, 2016
- Liarozole inhibits transforming growth factor-β3–mediated extracellular matrix formation in human three-dimensional leiomyoma culturesFertility and Sterility, 2014
- Leiomyoma fibrosis inhibited by liarozole, a retinoic acid metabolic blocking agentFertility and Sterility, 2012
- The estimated annual cost of uterine leiomyomata in the United StatesAmerican Journal of Obstetrics and Gynecology, 2012
- Myometrial cells undergo fibrotic transformation under the influence of transforming growth factor β-3Fertility and Sterility, 2010
- Novel method to characterize primary cultures of leiomyoma and myometrium with the use of confirmatory biomarker gene arraysFertility and Sterility, 2007
- A new hypothesis about the origin of uterine fibroids based on gene expression profiling with microarraysAmerican Journal of Obstetrics and Gynecology, 2006